NO20002787D0 - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20002787D0
NO20002787D0 NO20002787A NO20002787A NO20002787D0 NO 20002787 D0 NO20002787 D0 NO 20002787D0 NO 20002787 A NO20002787 A NO 20002787A NO 20002787 A NO20002787 A NO 20002787A NO 20002787 D0 NO20002787 D0 NO 20002787D0
Authority
NO
Norway
Prior art keywords
new connections
connections
new
Prior art date
Application number
NO20002787A
Other languages
English (en)
Other versions
NO20002787L (no
Inventor
Andrew Baxter
David Cheshire
Thomas Mcinally
Michael Mortimore
David Cladingboel
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO20002787D0 publication Critical patent/NO20002787D0/no
Publication of NO20002787L publication Critical patent/NO20002787L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20002787A 1997-12-05 2000-05-31 Nye forbindelser NO20002787L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704546A SE9704546D0 (sv) 1997-12-05 1997-12-05 Novel compounds
PCT/SE1998/002190 WO1999029686A1 (en) 1997-12-05 1998-12-01 Novel compounds

Publications (2)

Publication Number Publication Date
NO20002787D0 true NO20002787D0 (no) 2000-05-31
NO20002787L NO20002787L (no) 2000-08-01

Family

ID=20409283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002787A NO20002787L (no) 1997-12-05 2000-05-31 Nye forbindelser

Country Status (16)

Country Link
EP (1) EP1037889A1 (no)
JP (1) JP2001525406A (no)
KR (1) KR20010032800A (no)
CN (1) CN1284074A (no)
AU (1) AU1791599A (no)
BR (1) BR9813378A (no)
CA (1) CA2312357A1 (no)
EE (1) EE200000321A (no)
HU (1) HUP0100731A3 (no)
IL (1) IL136368A0 (no)
NO (1) NO20002787L (no)
PL (1) PL340837A1 (no)
SE (1) SE9704546D0 (no)
SK (1) SK8442000A3 (no)
TR (1) TR200001544T2 (no)
WO (1) WO1999029686A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901875D0 (sv) * 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
SE9904505D0 (sv) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
JP2002330787A (ja) * 2000-10-21 2002-11-19 Astrazeneca Ab 化学物質
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
MXPA05012086A (es) 2003-05-12 2006-02-22 Pfizer Prod Inc Inhibidores de benzamida del receptor p2x7.
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
WO2006003500A1 (en) 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
WO2007109172A2 (en) 2006-03-16 2007-09-27 Renovis, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為p2x7調節劑之雙環雜芳基化合物與其用途
BRPI0709596A2 (pt) 2006-03-16 2011-07-19 Renovis Inc compostos bicicloeteroarila como moduladores de p2x7 e seus usos
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
GB0613473D0 (en) * 2006-07-06 2006-08-16 Glaxo Group Ltd Novel compounds
CA2655675A1 (en) 2006-07-06 2008-01-10 Glaxo Group Limited Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
JP2010520875A (ja) 2007-03-09 2010-06-17 レノビス, インコーポレイテッド P2x7調節因子としてのビシクロヘテロアリール化合物およびその使用
WO2008116845A1 (en) * 2007-03-28 2008-10-02 Glaxo Group Limited Piperidinone carboxamide derivatives as p2x7 modulators
JP2010522710A (ja) * 2007-03-29 2010-07-08 グラクソ グループ リミテッド P2x7調節因子としてのオキサゾリジンおよびモルホリンカルボキサミド誘導体
CA2682649A1 (en) * 2007-04-03 2008-10-09 Glaxo Group Limited Imidazolidine carboxamide derivatives as p2x7 modulators
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
GB0803729D0 (en) * 2008-02-29 2008-04-09 Ge Healthcare Ltd Imaging the central nervous system
CN102046240B (zh) 2008-03-25 2014-06-25 阿费克蒂斯药品公司 新的p2x7r拮抗剂及其应用
WO2010118921A1 (en) 2009-04-14 2010-10-21 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
EP2322149A1 (en) 2009-11-03 2011-05-18 Universidad del Pais Vasco Methods and compositions for the treatment of ischemia
EP2569281A1 (en) 2010-05-14 2013-03-20 Affectis Pharmaceuticals AG Novel methods for the preparation of p2x7r antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2019102354A1 (en) 2017-11-21 2019-05-31 3M Innovative Properties Company Oral plant-based-oil-in-water emulsions and methods of use
JP7341143B2 (ja) 2017-12-20 2023-09-08 スリーエム イノベイティブ プロパティズ カンパニー 口腔用組成物及び使用方法
AU2018392187B2 (en) 2017-12-20 2022-01-20 Solventum Intellectual Properties Company Oral compositions and methods of use
WO2020136606A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
EP3902523A1 (en) 2018-12-29 2021-11-03 3M Innovative Properties Company Oral articles and methods of use

Also Published As

Publication number Publication date
AU1791599A (en) 1999-06-28
CN1284074A (zh) 2001-02-14
SE9704546D0 (sv) 1997-12-05
BR9813378A (pt) 2000-10-10
TR200001544T2 (tr) 2000-11-21
HUP0100731A2 (hu) 2002-05-29
PL340837A1 (en) 2001-02-26
HUP0100731A3 (en) 2002-08-28
WO1999029686A1 (en) 1999-06-17
IL136368A0 (en) 2001-06-14
SK8442000A3 (en) 2001-01-18
KR20010032800A (ko) 2001-04-25
EE200000321A (et) 2001-08-15
CA2312357A1 (en) 1999-06-17
JP2001525406A (ja) 2001-12-11
EP1037889A1 (en) 2000-09-27
NO20002787L (no) 2000-08-01

Similar Documents

Publication Publication Date Title
NO20000312L (no) Nye forbindelser
NO20002787D0 (no) Nye forbindelser
NO970374L (no) Nye forbindelser
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO973231D0 (no) Nye forbindelser
NO960472L (no) Nye forbindelser
DK0973746T3 (da) Substituerede 3-cyanoquinoliner
NO970512D0 (no) Nye heteroaryl-oksazolidinoner
ID24329A (id) Landasan lepas-pantai bergerak
DK0906288T3 (da) Nye forbindelser
NO20010860D0 (no) Nye forbindelser
DK1025107T3 (da) Fotokrome forbindelser
PT1036083E (pt) Novos 9a-azalidos
NO20010861D0 (no) Nye forbindelser
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
NO990072D0 (no) Nye forbindelser
NO20010584L (no) Nye forbindelser
ATE244705T1 (de) Substituierte 4-benzoyl-pyrazole
NO20011262D0 (no) Nye forbindelser
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole
ID24079A (id) Aminoheteroksiklilamida tersubstitusi
NO983505D0 (no) Nye fenantrider
DE69739606D1 (de) Ichten verbindungsstellen
DE59810960D1 (de) Substituierte phenyluracile

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application